Simple Catheter Biofilm Flow Model: Klebsiella Phages Disrupt E. coli Biofilms on Urinary Catheters Under Static and

Hoda Bseikri1, Slawomir Michniewski2, Eduardo Goicoechea Serrano3

  • 1School of Life Sciences, Gibbet Hill Campus, The University of Warwick, Coventry, United Kingdom.

PHAGE (New Rochelle, N.Y.)
|February 26, 2026
PubMed
Abstract

Insights

Phage therapy effectively reduced E. coli biofilms in a catheter model under flow conditions. This demonstrates phage therapy

Area of Science:

  • Microbiology
  • Bacteriology
  • Biofilm research

Background:

  • Bacterial biofilms present persistent infection challenges in healthcare.
  • Phage therapy is a potential biofilm eradication strategy, but its efficacy under dynamic flow requires investigation.

Purpose of the Study:

  • To evaluate the effectiveness of two novel phages, Llofrudd and Samara, against Klebsiella biofilms.
  • To assess phage impact on biofilm viability within a flow-based catheter model.

Main Methods:

  • Isolation and genomic characterization of novel phages Llofrudd and Samara.
  • Construction of a flow-based catheterized bladder model.
  • Assessment of phage efficacy on E. coli biofilm viability under static and flow conditions.

Main Results:

  • Phages Llofrudd and Samara were identified as the same species, infecting limited strains across Klebsiella aerogenes, Klebsiella pneumoniae, and E. coli.
  • Phage treatment significantly reduced E. coli biofilm viability in catheters.
  • Phage therapy promoted bacterial liberation from biofilms.

Conclusions:

  • Phage therapy shows significant potential for treating catheter-associated urinary tract infections (CAUTIs).
  • The study validates phage therapy's efficacy in a dynamic, flow-based biofilm model.